Igor S. Lukashevich
Affiliations: | Molecular Microbiology and Immunology | University of Maryland School of Medicine, Baltimore, MD, United States |
Area:
Immunology, Virology BiologyGoogle:
"Igor Lukashevich"Children
Sign in to add trainee| Marco A. Goicochea | grad student | 2011 | University of Maryland Medical School |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tretyakova I, Joh J, Lukashevich IS, et al. (2023) Live-Attenuated CHIKV Vaccine with Rearranged Genome Replicates and Induces Immune Response in Mice. Biorxiv : the Preprint Server For Biology |
| Reyna RA, Maruyama J, Mantlo EK, et al. (2022) Depletion of CD4 and CD8 T Cells Reduces Acute Disease and Is Not Associated with Hearing Loss in ML29-Infected STAT1-/- Mice. Biomedicines. 10 |
| Johnson DM, Cubitt B, Pfeffer TL, et al. (2021) Lassa Virus Vaccine Candidate ML29 Generates Truncated Viral RNAs Which Contribute to Interfering Activity and Attenuation. Viruses. 13 |
| Johnson DM, Sokoloski KJ, Jokinen JD, et al. (2020) Advanced Safety and Genetic Stability in Mice of a Novel DNA-Launched Venezuelan Equine Encephalitis Virus Vaccine with Rearranged Structural Genes. Vaccines. 8 |
| Johnson DM, Jokinen JD, Wang M, et al. (2020) Bivalent Junin & Machupo experimental vaccine based on alphavirus RNA replicon vector. Vaccine |
| Tretyakova I, Plante KS, Rossi SL, et al. (2020) Venezuelan equine encephalitis vaccine with rearranged genome resists reversion and protects non-human primates from viremia after aerosol challenge. Vaccine |
| Radoshitzky SR, Buchmeier MJ, Charrel RN, et al. (2019) ICTV Virus Taxonomy Profile: Arenaviridae. The Journal of General Virology |
| Tretyakova I, Tibbens A, Jokinen JD, et al. (2019) Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome. Vaccine |
| Lukashevich IS, Paessler S, de la Torre JC. (2019) Lassa virus diversity and feasibility for universal prophylactic vaccine. F1000research. 8 |
| Johnson DM, Jokinen JD, Lukashevich IS. (2019) Attenuated Replication of Lassa Virus Vaccine Candidate ML29 in STAT-1 Mice. Pathogens (Basel, Switzerland). 8 |